Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. - Wikidata - wikimedia - TriplyDB

Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.

Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.

http://www.wikidata.org/entity/Q37042094

about

Integrating Antiretroviral Strategies for Human Immunodeficiency Virus Prevention: Post- and Pre-Exposure Prophylaxis and Early Treatment Preexposure prophylaxis-related stigma: strategies to improve uptake and adherence - a narrative review How Stigma Surrounding the Use of HIV Preexposure Prophylaxis Undermines Prevention and Pleasure: A Call to Destigmatize "Truvada Whores"A pill for HIV prevention: déjà vu all over again?Preexposure prophylaxis for HIV prevention: where have we been and where are we going?Preventing HIV infection: pre-exposure and postexposure prophylaxis Pre-exposure prophylaxis for sexually-acquired HIV risk management: a review Antiretroviral pharmacology in mucosal tissues Divergent adherence estimates with pharmacokinetic and behavioural measures in the MTN-003 (VOICE) study Patterns and correlates of PrEP drug detection among MSM and transgender women in the Global iPrEx Study.Applying a PrEP Continuum of Care for Men Who Have Sex With Men in Atlanta, Georgia Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa Safety, adherence and acceptability of intermittent tenofovir/emtricitabine as HIV pre-exposure prophylaxis (PrEP) among HIV-uninfected Ugandan volunteers living in HIV-serodiscordant relationships: a randomized, clinical trial No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis Strong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP)Daily oral emtricitabine/tenofovir preexposure prophylaxis and herpes simplex virus type 2 among men who have sex with men Knowledge, Indications and Willingness to Take Pre-Exposure Prophylaxis among Transwomen in San Francisco, 2013 Adherence to Pre-Exposure Prophylaxis for HIV Prevention in a Clinical Setting How Much Do We Know about Drug Resistance Due to PrEP Use? Analysis of Experts' Opinion and Its Influence on the Projected Public Health Impact Antiretroviral Drug Activity in Macaques Infected during Pre-Exposure Prophylaxis Has a Transient Effect on Cell-Associated SHIV DNA Reservoirs Towards preparedness for PrEP: PrEP awareness and acceptability among MSM at high risk of HIV transmission who use sociosexual media in four Celtic nations: Scotland, Wales, Northern Ireland and The Republic of Ireland: an online survey.Disclosure of pharmacokinetic drug results to understand nonadherence Sexual Behavior Patterns and PrEP Dosing Preferences in a Large Sample of North American Men Who Have Sex With Men.High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US PrEP demonstration project.The HIV-Brazil cohort study: design, methods and participant characteristics.Provider attitudes toward oral preexposure prophylaxis for HIV prevention among high-risk men who have sex with men in Lima, Peru Importance of Drug Pharmacokinetics at the Site of Action Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation.Optimal costs of HIV pre-exposure prophylaxis for men who have sex with men FEM-PrEP: adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxis.HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention.Biomedical prevention: state of the science.Correlation between plasma, intracellular, and cervical tissue levels of raltegravir at steady-state dosing in healthy women.Pharmacokinetics of antiretrovirals in genital secretions and anatomic sites of HIV transmission: implications for HIV prevention.A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: the TARGET study.Study product adherence measurement in the iPrEx placebo-controlled trial: concordance with drug detection.Preferences for daily or intermittent pre-exposure prophylaxis regimens and ability to anticipate sex among HIV uninfected members of Kenyan HIV serodiscordant couples Pre-exposure prophylaxis accessibility research and evaluation (PrEPARE Study)Tenofovir diphosphate concentrations and prophylactic effect in a macaque model of rectal simian HIV transmission.HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial.

P2860

Q26778085-71EC8339-DB7E-46D5-AD6F-75CDBEE0434D Q26778293-CB7BB941-DC8A-4167-8CCD-6D96E5E893A7 Q26798250-D4C005AA-78C2-4CC3-AE9C-885455811E80 Q26824606-3D054C9E-7BC5-4710-9523-34C1D369BDB5 Q26825042-97249B03-F3D6-40DE-B874-CD3B04D4BA61 Q26828445-E262D858-F0E8-44C5-B8C6-8EB1B2ABF3A3 Q26849762-79124D62-8F4A-4711-8891-CF005D7160CC Q27014675-B63CB21F-9353-4885-83DD-C91D56230F17 Q27300707-F29503C0-16B1-4255-BBBA-264AA57CE5CA Q27313352-10AF1C27-67E0-4E2E-8E8B-07B017E88A2C Q28088473-B7F00ACD-A67D-4E63-ADCA-D02327A96CBC Q28533158-8BF4269C-7928-4FF6-A93A-68A8CBC6B1F1 Q28533828-811AEDC0-3F95-4A6C-89AC-3C7408520218 Q28537713-1CCF3B6C-A15F-458F-981C-58DD7B2CE6E4 Q28538457-9A595822-6B02-4775-9008-CD0834D6CB77 Q28540969-6428BBAD-9653-43CB-963F-CC4673E19D9E Q28547765-3EE9D9D4-F487-447E-9482-B40DCC9B8501 Q28552015-D604E728-48BA-435D-A0A1-EB2781CC38AF Q28552455-59A80169-9F71-4ADA-88C6-B3D0265BC239 Q28553127-905E15B5-FBF0-448C-B3D1-49C79BEF2771 Q30196896-CF856C6E-0276-4FCD-AB81-25FDB0766DDB Q30674432-71302814-74B3-4568-A683-D26C5C4D6334 Q30698590-37E16C4C-6BC2-4DC9-B620-E30891755A59 Q30877918-95F65162-EC80-4D6E-B6F4-DEA2CE9E4B37 Q33553184-EAF878C5-B5DB-478B-93B9-AC912F2279E9 Q33566562-E4A54317-0140-434E-8B17-79AAFF5F87C2 Q33648045-297A1F26-751A-42B8-8267-EAFA41902B20 Q33656112-F2F3E1A6-A58C-446E-B9E0-4DA1BFACA0FC Q33751621-E381EEAF-9D46-48F3-AF40-8A973A342D45 Q33762990-1A4B086B-A956-4483-9F14-209367CA768E Q33763000-28E2C735-758D-4DEC-9EB1-7F42E8EFEFF8 Q33765795-62E9AAAD-F419-4F40-87C7-003B7080B691 Q33798045-70A8CAAC-D4AF-4ADB-8C29-1A2162678CD6 Q33888718-5CD298F7-4C28-4708-AA80-0C1BABADC6BA Q33909720-07F805F3-413D-4B3D-B1D4-02C2FE4CE40C Q33948938-3E393146-C893-4AAB-B738-2EE1DDCA5370 Q34021932-ACFACE68-25F0-4F94-9C39-974CA6E209D5 Q34022009-58D4B850-933E-4015-B450-D1C1B31FB9B5 Q34034418-29466070-B65E-42BC-B999-0DC3D84C200E Q34046430-9128237D-B991-4D19-BB07-627A785F125F

P2860

Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.

http://www.wikidata.org/entity/Q37042094

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Emtricitabine-tenofovir concen ...... in men who have sex with men.

@en

Emtricitabine-tenofovir concen ...... in men who have sex with men.

@nl

type

label

Emtricitabine-tenofovir concen ...... in men who have sex with men.

@en

Emtricitabine-tenofovir concen ...... in men who have sex with men.

@nl

prefLabel

Emtricitabine-tenofovir concen ...... in men who have sex with men.

@en

Emtricitabine-tenofovir concen ...... in men who have sex with men.

@nl

P1433

Q37042094-409212B9-EA22-4635-B08E-64A292AB1734

P1476

Q37042094-C31D597B-301D-4B21-A5C9-92CB2067804B

P2093

Q37042094-05C5E083-3695-4CB4-B6E2-CA3DC7C2CCB9

Q37042094-165A4A71-EDA9-467F-AB62-5E8233D9AB42

Q37042094-2A10FC18-3A3B-4912-A14E-678E6CDDF9EE

Q37042094-34306E89-EE12-47D9-976A-D52FBD8FF98C

Q37042094-5D90E55E-6E60-44BE-989C-B6FFF81EEAB3

Q37042094-677964E3-007D-4E3A-AD3C-4D997233E487

Q37042094-7930EBE0-C770-40DF-BFAB-1A6B50505020

Q37042094-80DB9DAE-F9B3-45A2-B61A-25F9DAF61E53

Q37042094-86D16855-EA73-46D9-92CE-642C6079D39A

Q37042094-96DE06B7-09E5-4DC3-8013-F84E0E289DD8

P2860

Q37042094-016EA4A0-1034-4453-90BC-8EF2EDB0D0BB

Q37042094-0BC5EAEB-E496-4202-A30F-CD2C3737552C

Q37042094-11B9EEE3-60AF-4354-B62C-620C7216CB56

Q37042094-1EA1B7D0-E1EC-42AE-A4F3-5F725693F6F6

Q37042094-228907E4-D313-4838-BFFF-DDE68B25C6B2

Q37042094-3F3E7408-5361-42E3-B2BF-CDCA75D8EA61

Q37042094-538A8813-CA88-4708-9F39-172FC322FF8A

Q37042094-577FBC58-6A61-4024-A0C8-F41739268BCF

Q37042094-6073B141-FD2D-4C2A-BAAD-B19127FF0C3A

Q37042094-6255BCE2-FE49-411D-86B0-AAB65C674BBC

P304

Q37042094-BF0CC31D-4075-481D-832C-13A7FE918EB6

P31

Q37042094-1C0CD4E5-DD53-4B54-A143-12F813B7FFAA

P356

Q37042094-D96C9142-42AD-4E1C-BE9C-9675F2E28A54

P407

Q37042094-80F853A4-BFA6-458E-9F5E-38CBA0A99336

P433

Q37042094-9C5C58E1-780C-45BD-B724-349C96B88428

P478

Q37042094-FAA74C02-8A9B-404A-8B05-9E3AF2F7D31F

P50

Q37042094-204C4040-2FD4-407B-B34D-836EF4DD675C

Q37042094-573D5952-CBE1-4ECD-A4E7-0C218B6966EC

Q37042094-5F16B49A-7513-4A62-9024-58B21166FF51

Q37042094-7A0D0697-752C-45A4-A851-D759715FAA36

Q37042094-BEE80644-A51A-447D-83C4-CCBA16824D93

P577

Q37042094-397E9808-D4E6-4C51-A856-E46A62E2D908

P5875

Q37042094-9594B6A3-5A4A-465E-A5B4-A8735E0E5430

P698

Q37042094-2DB279F9-3438-4BE4-9943-5F210FC1398B

P921

Q37042094-9C3FE0D7-91FA-4233-8475-74C5A1304AF4

P932

Q37042094-1C279859-6E67-4C58-A524-83B9F6582065

P356

SCITRANSLMED.3004006

P1433

Science Translational Medicine

P1476

Emtricitabine-tenofovir concen ...... in men who have sex with men.

@en

P2093

Albert Liu

http://www.w3.org/2001/XMLSchema#string

David V Glidden

http://www.w3.org/2001/XMLSchema#string

Esper Georges Kallás

http://www.w3.org/2001/XMLSchema#string

Javier R Lama

http://www.w3.org/2001/XMLSchema#string

Lane R Bushman

http://www.w3.org/2001/XMLSchema#string

Martín Casapía

http://www.w3.org/2001/XMLSchema#string

Mauro Schechter

http://www.w3.org/2001/XMLSchema#string

Orlando Montoya-Herrera

http://www.w3.org/2001/XMLSchema#string

Peter L Anderson

http://www.w3.org/2001/XMLSchema#string

Suwat Chariyalertsak

http://www.w3.org/2001/XMLSchema#string

P2860

Elevated risk for HIV infection among men who have sex with men in low- and middle-income countries 2000-2006: a systematic review

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

Modelling clustered survival data from multicentre clinical trials.

Multiple imputation: a primer.

A randomized trial to assess anti-HIV activity in female genital tract secretions and soluble mucosal immunity following application of 1% tenofovir gel.

Plasma and intracellular population pharmacokinetic analysis of tenofovir in HIV-1-infected patients.

Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission.

Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir-ritonavir in adolescents and young adults with human immunodeficiency virus infection.

Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women.

Pre-exposure prophylaxis for HIV prevention: how to predict success.

P304

151ra125

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCITRANSLMED.3004006

http://www.w3.org/2001/XMLSchema#string

P407

P433

151

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Linda-Gail Bekker

Juan V. Guanira

Robert M. Grant

Susan Buchbinder

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230843437

http://www.w3.org/2001/XMLSchema#string

P698

22972843

http://www.w3.org/2001/XMLSchema#string

P921

men who have sex with men

P932

3721979

http://www.w3.org/2001/XMLSchema#string